BBOT Exits SPAC Process, Ready To Execute After Private Stint
03 Sep 2025 //
BIOSPACE
BBOT to Join September Investor Healthcare Conferences
20 Aug 2025 //
GLOBENEWSWIRE
BBOT Goes Public, Targets KRAS and PI3K Pathway Cancers
11 Aug 2025 //
GLOBENEWSWIRE
BBOT: First Patient Dosed with PanKRAS Inhibitor in KONQUER-101
01 Apr 2025 //
BUSINESSWIRE
BBO-8520 Preclinical Data in KRASG12C Mutant Tumors Published
09 Dec 2024 //
BUSINESSWIRE